Bioventus Inc.
BVS · NASDAQ
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $445,718 | $450,208 | $596,058 | $687,245 |
| - Cash | $42,164 | $32,910 | $22,802 | $41,582 |
| + Debt | $11,250 | $341,238 | $345,932 | $335,627 |
| Enterprise Value | $414,804 | $758,536 | $919,188 | $981,290 |
| Revenue | $138,651 | $147,660 | $123,876 | $153,642 |
| % Growth | -6.1% | 19.2% | -19.4% | – |
| Gross Profit | $92,831 | $102,090 | $83,056 | $102,656 |
| % Margin | 67% | 69.1% | 67% | 66.8% |
| EBITDA | $22,250 | $29,856 | $15,957 | $21,634 |
| % Margin | 16% | 20.2% | 12.9% | 14.1% |
| Net Income | $3,155 | $7,459 | -$2,637 | -$156 |
| % Margin | 2.3% | 5.1% | -2.1% | -0.1% |
| EPS Diluted | 0.046 | 0.11 | -0.04 | -0.002 |
| % Growth | -58.4% | 375% | -1,900% | – |
| Operating Cash Flow | $30,098 | $25,938 | -$19,331 | $19,322 |
| Capital Expenditures | -$473 | -$683 | -$826 | -$574 |
| Free Cash Flow | $29,625 | $25,255 | -$20,157 | $18,748 |